Effect of early versus delayed interferon beta-1b treatment on disability after a fi rst clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study Effect of early versus delayed interferon beta-1b treatment on disability after a fi rst clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study2018-01-17T17:03:31-05:00
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:01:13-05:00
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:00:50-05:00
